PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CIPLA.NS vs. SUNPHARMA.NS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


CIPLA.NSSUNPHARMA.NS
YTD Return12.54%21.97%
1Y Return54.17%63.83%
3Y Return (Ann)16.87%32.20%
5Y Return (Ann)22.12%32.31%
10Y Return (Ann)14.60%10.57%
Sharpe Ratio1.983.34
Daily Std Dev25.27%18.19%
Max Drawdown-86.45%-71.46%
Current Drawdown-6.53%-6.25%

Fundamentals


CIPLA.NSSUNPHARMA.NS
Market Cap₹1.08T₹3.63T
EPS₹45.93₹37.06
PE Ratio29.1740.88
Revenue (TTM)₹251.16B₹474.45B
Gross Profit (TTM)₹145.01B₹332.24B
EBITDA (TTM)₹61.30B₹128.15B

Correlation

-0.50.00.51.00.4

The correlation between CIPLA.NS and SUNPHARMA.NS is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

CIPLA.NS vs. SUNPHARMA.NS - Performance Comparison

In the year-to-date period, CIPLA.NS achieves a 12.54% return, which is significantly lower than SUNPHARMA.NS's 21.97% return. Over the past 10 years, CIPLA.NS has outperformed SUNPHARMA.NS with an annualized return of 14.60%, while SUNPHARMA.NS has yielded a comparatively lower 10.57% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


150.00%200.00%250.00%300.00%350.00%December2024FebruaryMarchAprilMay
196.96%
327.24%
CIPLA.NS
SUNPHARMA.NS

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Cipla Limited

Sun Pharmaceutical Industries Limited

Risk-Adjusted Performance

CIPLA.NS vs. SUNPHARMA.NS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cipla Limited (CIPLA.NS) and Sun Pharmaceutical Industries Limited (SUNPHARMA.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CIPLA.NS
Sharpe ratio
The chart of Sharpe ratio for CIPLA.NS, currently valued at 1.87, compared to the broader market-2.00-1.000.001.002.003.004.001.87
Sortino ratio
The chart of Sortino ratio for CIPLA.NS, currently valued at 2.77, compared to the broader market-4.00-2.000.002.004.006.002.77
Omega ratio
The chart of Omega ratio for CIPLA.NS, currently valued at 1.35, compared to the broader market0.501.001.502.001.35
Calmar ratio
The chart of Calmar ratio for CIPLA.NS, currently valued at 2.17, compared to the broader market0.002.004.006.002.17
Martin ratio
The chart of Martin ratio for CIPLA.NS, currently valued at 10.64, compared to the broader market-10.000.0010.0020.0030.0010.64
SUNPHARMA.NS
Sharpe ratio
The chart of Sharpe ratio for SUNPHARMA.NS, currently valued at 3.19, compared to the broader market-2.00-1.000.001.002.003.004.003.19
Sortino ratio
The chart of Sortino ratio for SUNPHARMA.NS, currently valued at 4.27, compared to the broader market-4.00-2.000.002.004.006.004.27
Omega ratio
The chart of Omega ratio for SUNPHARMA.NS, currently valued at 1.55, compared to the broader market0.501.001.502.001.55
Calmar ratio
The chart of Calmar ratio for SUNPHARMA.NS, currently valued at 1.60, compared to the broader market0.002.004.006.001.60
Martin ratio
The chart of Martin ratio for SUNPHARMA.NS, currently valued at 20.85, compared to the broader market-10.000.0010.0020.0030.0020.85

CIPLA.NS vs. SUNPHARMA.NS - Sharpe Ratio Comparison

The current CIPLA.NS Sharpe Ratio is 1.98, which is lower than the SUNPHARMA.NS Sharpe Ratio of 3.34. The chart below compares the 12-month rolling Sharpe Ratio of CIPLA.NS and SUNPHARMA.NS.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00December2024FebruaryMarchAprilMay
1.87
3.19
CIPLA.NS
SUNPHARMA.NS

Dividends

CIPLA.NS vs. SUNPHARMA.NS - Dividend Comparison

CIPLA.NS's dividend yield for the trailing twelve months is around 0.60%, less than SUNPHARMA.NS's 0.82% yield.


TTM20232022202120202019201820172016201520142013
CIPLA.NS
Cipla Limited
0.60%0.68%0.46%0.53%0.12%0.63%0.58%0.33%0.35%0.31%0.32%0.50%
SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
0.82%0.91%1.00%0.89%0.68%0.64%0.46%0.61%0.16%0.37%0.18%0.44%

Drawdowns

CIPLA.NS vs. SUNPHARMA.NS - Drawdown Comparison

The maximum CIPLA.NS drawdown since its inception was -86.45%, which is greater than SUNPHARMA.NS's maximum drawdown of -71.46%. Use the drawdown chart below to compare losses from any high point for CIPLA.NS and SUNPHARMA.NS. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%December2024FebruaryMarchAprilMay
-7.30%
-6.25%
CIPLA.NS
SUNPHARMA.NS

Volatility

CIPLA.NS vs. SUNPHARMA.NS - Volatility Comparison

Cipla Limited (CIPLA.NS) has a higher volatility of 10.40% compared to Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) at 6.31%. This indicates that CIPLA.NS's price experiences larger fluctuations and is considered to be riskier than SUNPHARMA.NS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%December2024FebruaryMarchAprilMay
10.40%
6.31%
CIPLA.NS
SUNPHARMA.NS

Financials

CIPLA.NS vs. SUNPHARMA.NS - Financials Comparison

This section allows you to compare key financial metrics between Cipla Limited and Sun Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in INR except per share items